Adjuvant treatment for high-risk salivary gland malignancies and prognostic stratification based on a 20-year single institution experience.

MLA

Onderdonk, Benjamin E., et al. “Adjuvant Treatment for High-Risk Salivary Gland Malignancies and Prognostic Stratification Based on a 20-Year Single Institution Experience.” Health Science Reports, vol. 3, no. 4, Oct. 2020, p. e195. EBSCOhost, https://doi.org/10.1002/hsr2.195.

APA

Onderdonk, B. E., Vokes, E. E., Gwede, M., Blair, E., Agrawal, N., & Haraf, D. J. (2020). Adjuvant treatment for high-risk salivary gland malignancies and prognostic stratification based on a 20-year single institution experience. Health Science Reports, 3(4), e195. https://doi.org/10.1002/hsr2.195

Chicago

Onderdonk, Benjamin E, Everett E Vokes, Michael Gwede, Elizabeth Blair, Nishant Agrawal, and Daniel J Haraf. 2020. “Adjuvant Treatment for High-Risk Salivary Gland Malignancies and Prognostic Stratification Based on a 20-Year Single Institution Experience.” Health Science Reports 3 (4): e195. doi:10.1002/hsr2.195.